S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
Log in
NASDAQ:UTMD

Utah Medical Products Stock Forecast, Price & News

$83.98
+1.24 (+1.50 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
$82.57
Now: $83.98
$83.98
50-Day Range
$78.22
MA: $81.26
$84.49
52-Week Range
$75.33
Now: $83.98
$112.26
Volume5,482 shs
Average Volume13,832 shs
Market Capitalization$305.94 million
P/E Ratio24.99
Dividend Yield1.35%
Beta0.33
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.
Read More
Utah Medical Products logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:UTMD
CUSIP91748810
Phone801-566-1200
Employees173

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$46.90 million
Cash Flow$6.04 per share
Book Value$27.17 per share

Profitability

Net Income$14.73 million

Miscellaneous

Market Cap$305.94 million
Next Earnings Date10/22/2020 (Estimated)
OptionableNot Optionable
$83.98
+1.24 (+1.50 %)
(As of 10/20/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

How has Utah Medical Products' stock been impacted by COVID-19 (Coronavirus)?

Utah Medical Products' stock was trading at $88.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, UTMD stock has decreased by 5.1% and is now trading at $83.98.
View which stocks have been most impacted by COVID-19
.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Utah Medical Products
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) released its quarterly earnings results on Tuesday, July, 28th. The medical instruments supplier reported $0.36 EPS for the quarter. The medical instruments supplier earned $8.79 million during the quarter. Utah Medical Products had a net margin of 28.44% and a return on equity of 12.38%.
View Utah Medical Products' earnings history
.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a quarterly dividend on Wednesday, August 12th. Shareholders of record on Tuesday, September 15th will be given a dividend of $0.28 per share on Monday, October 5th. This represents a $1.12 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date is Monday, September 14th.
View Utah Medical Products' dividend history
.

Who are some of Utah Medical Products' key competitors?

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), The Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and Axon Enterprise (AAXN).

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 72)
  • Mr. Brian L. Koopman, Principal Financial Officer & Controller

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Clean Yield Group (0.71%), Cardinal Capital Management (0.26%) and Denali Advisors LLC (0.01%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Brian Koopman and Kevin L Cornwell.
View institutional ownership trends for Utah Medical Products
.

Which institutional investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, and Clean Yield Group. Company insiders that have sold Utah Medical Products company stock in the last year include Barbara A Payne, Brian Koopman, and Kevin L Cornwell.
View insider buying and selling activity for Utah Medical Products
.

Which institutional investors are buying Utah Medical Products stock?

UTMD stock was purchased by a variety of institutional investors in the last quarter, including Cardinal Capital Management.
View insider buying and selling activity for Utah Medical Products
.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $83.98.

How big of a company is Utah Medical Products?

Utah Medical Products has a market capitalization of $305.94 million and generates $46.90 million in revenue each year. Utah Medical Products employs 173 workers across the globe.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is www.utahmed.com.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.

This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.